Clinical Study

Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus

Table 3

Univariate logistic regression analysis (CAN+, CAN− patient groups).

VariableOdds ratio95% CIP value

Male/Female0.900.4682 to 1.75690.772
Age (years)1.020.9864 to 1.06880.19
Age diabetes dg. (years)0.890.8571 to 0.9402<0,0001
Diabetes duration (years)1.67971.4278 to 1.97600.0001
Body mass index (kg/m2)1.131.0588 to 1.21390.0003
SBP (mmHg)1.011.0000 to 1.03600.05
DBP (mmHg)1.00460.9710 to 1.03940.78
HT (yes)1.560.7656 to 3.20240.21
SCORE1.121.0425 to 1.20690.002
Smoking (yes versus no)2.221.1327 to 4.35980.02
Severity of smoking (>20 versus <20 cigarettes/day)1.290.4773 to 3.51480.6115
Cholesterol (mg%)1.011.0041 to 1.01890.0023
Triglycerides (mg%)1.00240.9999 to 1.00490.0633
HbA1c1.831.3826 to 2.4302<0.0001
Treatment of diabetes3.00001.3458 to 6.68730.0072
FPG (mg%)1.00611.0008 to 1.01150.02
eGFR (mL/min per 1.73 m2) 0.900.8808 to 0.9376<0.0001
ABI0.00460.0002 to 0.09440.0005
QTC1.051.0341 to 1.0728<0.0001
IMT12.488.21 to 18.32<0.0001
Retinopathy (yes versus no)16.53062.0342 to 134.33470.008
Peripheral neuropathy (yes versus no)29.944412.0439 to 74.45030.0001

SBP: systolic blood pressure, DBP: diastolic blood pressure, HT: hypertension, SCORE: systematic coronary risk evaluation, HbA1c: glycosylated hemoglobin, FPG: fasting plasma glucose, eGFR: estimated glomerular filtration rate, ABI: ankle-brachial index, IMT: intima-media thickness, and QTC: corrected QT interval.